Ferrante Karen Jean 4
4 · Cogent Biosciences, Inc. · Filed Jun 5, 2025
Insider Transaction Report
Form 4
Ferrante Karen Jean
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-04+44,700→ 44,700 totalExercise: $5.64Exp: 2035-06-04→ Common Stock (44,700 underlying)
Footnotes (1)
- [F1]This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2026 Annual Meeting of Stockholders.